PharmaBoardroom

The Deputy Executive Secretary of Taiwan's National Development Fund discusses the recent shift in focus from semiconductors to biotech investments;…

The Vice President of Merits Health Products discusses the company’s main opportunities and challenges of the past 25 years, which countries are…

Country Manager of Norpharma, Denmark, discusses how the company has been able to remain a market competitor while maintaining satisfactory payer…

Anders Blanck of Lif Sweden discusses the Swedish healthcare system, why it’s contributing to the plunging profit margins in the pharma market, and…

Mario Piccinin and Lara Iob of EY Canada discuss some of the key trends of the country’s biotech industry and the affiliate’s dedication to…

Chairman of YFY Biotech Management Company discusses the remarkable history of the company, why Taiwan is such an innovative country in the biotech…

President of TWi Pharmaceuticals discusses soaring tax rates in the US market, why Taiwan is a more attractive market to currently build in and…

The Chairman of Taiwan Advance Bio-Pharmaceutical Inc. discusses the challenges and opportunities TABP has faced in its transformation into a…

The chairman & CEO of General Biological Corp. (GBC) discusses the company’s rocky start and how GBC was able to overcome the initial…

Chairman of Formosa Laboratories discusses the company’s early presence on the global stage, the rise of lost-cost API players like India and China…

Vice Chairman of Parexel discusses the benefit of building a company in Taiwan, and the company’s long and short-term goals both domestically and…

President & Chair of Life Sciences discusses why Canada is not a global competitor in the Life Sciences industry and what needs to change…